Anders Edsjö (Former)
1 – 20 of 31
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
UROSCAN and UROSCANSEQ : a large-scale multicenter effort towards translation of molecular bladder cancer subtypes into clinical practice–from biobank to RNA-sequencing in real time
(
- Contribution to journal › Article
-
Mark
KRAS G12C Mutant Non–Small Cell Lung Cancer Linked to Female Sex and High Risk of CNS Metastasis : Population-based Demographics and Survival Data From the National Swedish Lung Cancer Registry
(
- Contribution to journal › Article
- 2022
-
Mark
Trailblazing precision medicine in Europe : A joint view by Genomic Medicine Sweden and the Centers for Personalized Medicine, ZPM, in Germany
(
- Contribution to journal › Article
- 2021
-
Mark
Quantification of microRNA editing using two-tailed RT-qPCR for improved biomarker discovery
(
- Contribution to journal › Article
-
Mark
Molekylär patologi – nyckeln till målinriktad cancerbehandling
(
- Contribution to journal › Article
- 2016
-
Mark
The expression pattern of matrix-producing tumor stroma is of prognostic importance in breast cancer
(
- Contribution to journal › Article
- 2015
-
Mark
miR-145 suppress the androgen receptor in prostate cancer cells and correlates to prostate cancer prognosis.
(
- Contribution to journal › Article
-
Mark
miR-183 in Prostate Cancer Cells Positively Regulates Synthesis and Serum Levels of Prostate-specific Antigen.
(
- Contribution to journal › Article
-
Mark
Prognostic stromal gene signatures in breast cancer.
(
- Contribution to journal › Article
- 2013
-
Mark
Upregulation of miR-96 Enhances Cellular Proliferation of Prostate Cancer Cells through FOXO1.
(
- Contribution to journal › Article
-
Mark
Automatic registration of multi-modal microscopy images for integrative analysis of prostate tissue sections
(
- Contribution to journal › Article
-
Mark
miR-205 negatively regulates the androgen receptor and is associated with adverse outcome of prostate cancer patients.
(
- Contribution to journal › Article
-
Mark
Preparation of DNA from cytological material: Effects of Fixation, Staining, and Mounting Medium on DNA Yield and Quality.
(
- Contribution to journal › Article
-
Mark
miQ - a novel microRNA based diagnostic and prognostic tool for prostate cancer.
(
- Contribution to journal › Article
-
Mark
The tumour suppressor miR-34c targets MET in prostate cancer cells.
(
- Contribution to journal › Article
-
Mark
A high-density tissue microarray from patients with clinically localized prostate cancer reveals ERG and TATI exclusivity in tumor cells.
(
- Contribution to journal › Article
- 2012
-
Mark
Do Pre-Analytical Parameters Explain KRAS Test Sensitivity Disparities? Reply
(
- Contribution to journal › Letter
-
Mark
Implementation of Formalin-Fixed, Paraffin-Embedded Cell Line Pellets as High-Quality Process Controls in Quality Assessment Programs for KRAS Mutation Analysis
(
- Contribution to journal › Article
- 2011
-
Mark
Elevated level of wnt5a protein in localized prostate cancer tissue is associated with better outcome.
(
- Contribution to journal › Article
-
Mark
Systematic Analysis of MicroRNAs Targeting the Androgen Receptor in Prostate Cancer Cells.
(
- Contribution to journal › Article